Fucil

Fucil

fluorouracil

Manufacturer:

UNILAB, Inc

Distributor:

UNILAB, Inc
Concise Prescribing Info
Contents
Fluorouracil
Indications/Uses
Advanced colorectal carcinoma as monotherapy or in combination w/ leucovorin. In combination chemotherapy as an adjunct to surgery in women w/ breast cancer.
Dosage/Direction for Use
IV infusion 15 mg/kg daily over 4 hr. Alternatively daily dose may be infused over 30-60 min or may be given as a continuous IV infusion over 24 hr. Max: 1 g. IV inj 12 mg/kg daily for 4 consecutive days. If no toxic effects are observed, 6 mg/kg on days 6, 8, 10 & 12. Max: 800 mg. Alternatively, 15 mg/kg as single IV inj once a wk throughout the course. Intra-arterial infusion 5-7.5 mg/kg/day as 24-hr intra-arterial continuous drip infusion. Maintenance therapy: Initial therapy should be repeated at intervals of 30 days after the last dose of the previous course. Alternatively when toxicity from initial course of therapy has subsided, 10-15 mg/kg single wkly maintenance may be administered. Max: 1 g. Combination therapy w/ leucovorin: 9-10 mg/kg IV inj for 5 days after 5-12 mg/kg leucovorin for 5 days, repeat course every 4 wk. Poor risk patient IV inj Initial dose: 6 mg/kg/day for 3 days. If no toxic manifestations are observed, 3 mg/kg is given on days 5, 7, 9. Repeat course every 30 days. Max: 400 mg. IV infusion 6 mg/kg diluted in 500 mL 0.9% NaCl or 5% dextrose given once a day over 4 hr until signs of toxicity are observed usually w/in 8-15 days.
Contraindications
Hypersensitivity. Poor nutritional state, dihydropyrimidine dehydrogenase enzyme deficiency, depressed bone marrow function, potentially serious infection, management of non-malignant disease. Pregnancy & lactation.
Special Precautions
Discontinue if significant leukopenia (<3,500/mm3) or granulocytopenia (<1,500/mm3) occurs. GI effects. Perform leukocyte counts w/ differential prior to each dose. Patients w/ chest pain during courses of treatment of those w/ heart disease; who have undergone major surgery w/in previous 30 days; previously received high-dose irradiation therapy to bone-marrow bearing areas eg, pelvis, spine, ribs or alkylating agents. Severe neurological toxicity. Renal &/or hepatic dysfunction. May affect ability to drive & use heavy machinery. Childn. Elderly.
Adverse Reactions
Anorexia, nausea & vomiting; stomatitis, esophagopharyngitis. Leukopenia, thrombocytopenia, anemia; hypersensitivity reactions; alopecia, maculopapular rash; oculomotor disturbances; conjuctivitis; CV effects; hepatocellular damage; immunosuppression; fever.
Drug Interactions
Increased plasma conc w/ nucleoside analogues, cimetidine, & interferon α-2b. Reduced clearance w/ metronidazole. Occurrence of hemolytic-uremic syndrome w/ mitomycin. May elevate plasma conc of phenytoin. Increased risk of agranulocytosis w/ clozapine. Enhanced DNA-directed toxicity w/ leucovorin. Methotrexate. Sorafenib. Elevated PT & INR w/ warfarin.
MIMS Class
Cytotoxic Chemotherapy
ATC Classification
L01BC02 - fluorouracil ; Belongs to the class of antimetabolites, pyrimidine analogues. Used in the treatment of cancer.
Presentation/Packing
Form
Fucil soln for inj 500 mg/10 mL
Packing/Price
1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in